Advertisement

Midterm results of conjunctival reconstruction with buccal mucosa and amniotic membrane after resecting ocular surface squamous neoplasia of the fornix

Published:August 05, 2022DOI:https://doi.org/10.1016/j.jcjo.2022.07.003

      Abstract

      Objective

      To evaluate the midterm results of tumour resection with or without adjunctive therapy for ocular surface squamous neoplasia of the fornix, including conjunctival reconstruction with buccal mucosa and amniotic membrane.

      Methods

      A retrospective case-series analysis including slit-lamp examination, photographic documentation, and biopsy results (repeated when clinical findings changed). Analysis centred on eye function, complications, additional procedures, and recurrence rate. Surgical technique included tumour resection and subsequent reconstruction of lost conjunctiva with buccal mucosa and amniotic membrane.

      Results

      We included 83 affected eyes from 76 patients (mean age, 63.10 ± 14.45 years; 34 females) seen over a mean follow-up period of 26.56 ± 21.17 months. We achieved bulbus oculi salvage in 82 eyes (98.79%) and typically preserved visual acuity (mean 0.2 ± 0.5 logMAR and 0.3 ± 0.5 logMAR at presentation and last follow-up, respectively). Moreover, only 23 patients (27.71%) required corrective surgery for clinically relevant complications. The main complications included symblepharon (9.64%; n = 8), cicatricial ectropion (9.64%; n = 8), pannus (9.64%; n = 8), and corneal decompensation (8.43%; n = 7). Local tumour recurrence was seen in 23 patients (27.71%).

      Conclusions

      These midterm results confirm the efficacy of conjunctival reconstruction with amniotic membrane and buccal mucosa after resection of ocular surface squamous neoplasia from the fornix with palpebral and bulbar conjunctiva involvement. We not only achieved good tumour control and organ salvage with high levels of organ preservation but we also achieved good functional outcomes and acceptable recurrence rates. All clinically significant complications could be corrected in separate procedures.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Canadian Journal of Ophthalmology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Gichuhi S
        • Sagoo MS
        • Weiss HA
        • Burton MJ.
        Epidemiology of ocular surface squamous neoplasia in Africa.
        Trop Med Int Health. 2013; 18: 1424-1443
        • Gichuhi S
        • Ohnuma S
        • Sagoo MS
        • Burton MJ.
        Pathophysiology of ocular surface squamous neoplasia.
        Exp Eye Res. 2014; 129: 172-182
        • Lee GA
        • Hirst LW.
        Ocular surface squamous neoplasia.
        Surv Ophthalmol. 1995; 39: 429-450
        • Kim JW
        • Abramson DH.
        Topical treatment options for conjunctival neoplasms.
        Clin Ophthalmol. 2008; 2: 503-515
        • Schallenberg M
        • Niederdraing N
        • Steuhl KP
        • Meller D.
        Topical mitomycin C as a therapy of conjunctival tumours.
        Ophthalmologe. 2008; 105: 777-784
        • Galor A
        • Karp CL
        • Chhabra S
        • et al.
        Topical interferon alpha 2b eye-drops for treatment of ocular surface squamous neoplasia: a dose comparison study.
        Br J Ophthalmol. 2010; 94: 551-554
        • Karp CL
        • Galor A
        • Chhabra S
        • et al.
        Subconjunctival/perilesional recombinant interferon alpha 2b for ocular surface squamous neoplasia: a 10-year review.
        Ophthalmology. 2010; 117: 2241-2246
        • Russell HC
        • Chadha V
        • Lockington D
        • Kemp EG.
        Topical mitomycin C chemotherapy in the management of ocular surface neoplasia: a 10-year review of treatment outcomes and complications.
        Br J Ophthalmol. 2010; 94: 1316-1321
        • Birkholz ES
        • Goins KM
        • Sutphin JE
        • et al.
        Treatment of ocular surface squamous cell intraepithelial neoplasia with and without mitomycin C.
        Cornea. 2011; 30: 37-41
        • Siedlecki AN
        • Tapp S
        • Tosteson AN
        • et al.
        Surgery versus interferon alpha-2b treatment strategies for ocular surface squamous neoplasia: a literature-based decision analysis.
        Cornea. 2016; 35: 613-618
        • Chauhan S
        • Sen S
        • Sharma A
        • et al.
        American joint committee on cancer staging and clinicopathological high-risk predictors of ocular surface squamous neoplasia: a study from a tertiary eye center in India.
        Arch Pathol Lab Med. 2014; 138: 1488-1494
        • Ben SGJ
        • Schwarcz RM
        • Douglas R
        • et al.
        Orbital exenteration: one size does not fit all.
        Am J Ophthalmol. 2005; 139: 11-17
        • Espana EM
        • Prabhasawat P
        • Grueterich M
        • et al.
        Amniotic membrane transplantation for reconstruction after excision of large ocular surface neoplasias.
        Br J Ophthalmol. 2002; 86: 640-645
        • Solomon A
        • Espana EM
        • Tseng SC.
        Amniotic membrane transplantation for reconstruction of the conjunctival fornices.
        Ophthalmology. 2003; 110: 93-100
        • Dua HS
        • Gomes JA
        • King AJ
        • Maharajan VS.
        The amniotic membrane in ophthalmology.
        Surv Ophthalmol. 2004; 49: 51-77
        • Meller D
        • Pauklin M
        • Thomasen H
        • et al.
        Amniotic membrane transplantation in the human eye.
        Dtsch Arztebl Int. 2011; 108: 243-248
        • Liu J
        • Sheha H
        • Fu Y
        • et al.
        Oral mucosal graft with amniotic membrane transplantation for total limbal stem cell deficiency.
        Am J Ophthalmol. 2011; 152 (739–47e1)
        • Mai C
        • Bertelmann E.
        Oral mucosal grafts: old technique in new light.
        Ophthalmic Res. 2013; 50: 91-98
        • Emesz M
        • Krall EM
        • Rasp M
        • et al.
        Transplants from the hard palate: method for mucosal graft reconstruction of the upper eyelid.
        Ophthalmologe. 2014; 111: 853-861
        • Henderson HW
        • Collin JR.
        Mucous membrane grafting.
        Dev Ophthalmol. 2008; 41: 230-242
        • Nagasaki T
        • Zhao J.
        Uniform distribution of epithelial stem cells in the bulbar conjunctiva.
        Invest Ophthalmol Vis Sci. 2005; 46: 126-132
        • Heinz C
        • Fanihagh F
        • Steuhl KP.
        Squamous cell carcinoma of the conjunctiva in patients with atopic eczema.
        Cornea. 2003; 22: 135-137
        • Lopez GJS
        • Elosua DJI
        • Gonzalez MML
        • et al.
        Squamous cell carcinoma of the conjunctiva with orbital invasion.
        Arch Soc Esp Oftalmol. 2000; 75: 637-641
        • Shields CL
        • Shields JA.
        Tumours of the conjunctiva and cornea.
        Surv Ophthalmol. 2004; 49: 3-24
        • Damato B
        • Coupland SE.
        Clinical mapping of conjunctival melanomas.
        Br J Ophthalmol. 2008; 92: 1545-1549
        • Palamar M
        • Kaya E
        • Egrilmez S
        • et al.
        Amniotic membrane transplantation in surgical management of ocular surface squamous neoplasias: long-term results.
        Eye (Lond). 2014; 28: 1131-1135
        • Hughes WL.
        Total lower lid reconstruction: technical details.
        Trans Am Ophthalmol Soc. 1976; 74: 321-329
        • Pauklin M
        • Fuchsluger TA
        • Westekemper H
        • et al.
        Midterm results of cultivated autologous and allogeneic limbal epithelial transplantation in limbal stem cell deficiency.
        Dev Ophthalmol. 2010; 45: 57-70
        • Meller D
        • Thomasen H
        • Steuhl KP.
        Ocular surface reconstruction in limbal stem cell deficiency: transplantation of cultivated limbal epithelium.
        Ophthalmologe. 2012; 109: 863-868
        • Inatomi T
        • Nakamura T
        • Koizumi N
        • et al.
        Midterm results on ocular surface reconstruction using cultivated autologous oral mucosal epithelial transplantation.
        Am J Ophthalmol. 2006; 141: 267-275
        • Nakamura T
        • Takeda K
        • Inatomi T
        • et al.
        Long-term results of autologous cultivated oral mucosal epithelial transplantation in the scar phase of severe ocular surface disorders.
        Br J Ophthalmol. 2011; 95: 942-946
        • Kim JH
        • Chun YS
        • Lee SH
        • et al.
        Ocular surface reconstruction with autologous nasal mucosa in cicatricial ocular surface disease.
        Am J Ophthalmol. 2010; 149: 45-53
        • Galor A
        • Karp CL
        • Oellers P
        • et al.
        Predictors of ocular surface squamous neoplasia recurrence after excisional surgery.
        Ophthalmology. 2012; 119: 1974-1981
        • El-Hadad C
        • Rubin ML
        • Nagarajan P
        • et al.
        Ophthalmic Plast Reconstr Surg. 2021; 37: 262-268
        • Shields CL
        • Naseripour M
        • Shields JA.
        Topical mitomycin C for extensive, recurrent conjunctival-corneal squamous cell carcinoma.
        Am J Ophthalmol. 2002; 133: 601-606
        • Kim HJ
        • Shields CL
        • Shah SU
        • et al.
        Giant ocular surface squamous neoplasia managed with interferon alpha-2b as immunotherapy or immunoreduction.
        Ophthalmology. 2012; 119: 938-944
        • Besley J
        • Pappalardo J
        • Lee GA
        • et al.
        Risk factors for ocular surface squamous neoplasia recurrence after treatment with topical mitomycin C and interferon alpha-2b.
        Am J Ophthalmol. 2014; 157 (e2): 287-293
        • Peksayar G
        • Altan-Yaycioglu R
        • Onal S.
        Excision and cryosurgery in the treatment of conjunctival malignant epithelial tumours.
        Eye (Lond). 2003; 17: 228-232
        • Li AS
        • Shih CY
        • Rosen L
        • et al.
        Recurrence of ocular surface squamous neoplasia treated with excisional biopsy and cryotherapy.
        Am J Ophthalmol. 2015; 160: 213-219